04:40 AM EST, 12/05/2024 (MT Newswires) -- Biogen (BIIB) and Eisai said Wednesday the Federal Commission for the Protection Against Sanitary Risk in Mexico has approved Leqembi for the treatment of early Alzheimer's disease. The approval is based on a phase 3 study, which met its primary endpoint and all key endpoints with statistically significant results, the company said. Eisai...

04:31 AM EST, 12/05/2024 (MT Newswires) -- United Microelectronics ( UMC ) said Thursday its November revenue rose 6.7% to 20.05 billion New Taiwan dollars ($618.1 million) from NT$18.79 billion a year earlier. For the first 11 months of the year, revenue increased by 3.8% to NT$213.34 billion from NT$205.55 billion a year earlier. ...

MicroStrategy Inc. ( MSTR ) shares jumped 8.13% in pre-market trading on Thursday after Bitcoin (CRYPTO: BTC) surpassed $100,000 for the first time, continuing the software company’s stellar performance in 2024. What Happened: The company’s stock reached $438.43 in pre-market trading, building on Wednesday’s close of $406.00. MicroStrategy ( MSTR ), which holds approximately $40 billion in Bitcoin, has seen...

04:51 AM EST, 12/05/2024 (MT Newswires) -- Mesoblast (MESO) said late Wednesday the US Food and Drug Administration granted the company's second-generation cell therapy, Revascor, a regenerative medicine advanced therapy designation. The decision on the industrially manufactured stromal cell therapy follows the submission of results from a randomized controlled trial in children with hypoplastic left heart syndrome, which the company...